| Absorption and disposition of ginsenosides after oral administration of Panax notoginseng extract to rats H Liu, J Yang, F Du, X Gao, X Ma, Y Huang, F Xu, W Niu, F Wang, Y Mao, ... Drug Metabolism and Disposition 37 (12), 2290-2298, 2009 | 402 | 2009 |
| Pharmacokinetics of ranibizumab in patients with neovascular age-related macular degeneration: a population approach L Xu, T Lu, L Tuomi, N Jumbe, J Lu, S Eppler, P Kuebler, ... Investigative ophthalmology & visual science 54 (3), 1616-1624, 2013 | 218 | 2013 |
| Comparative pharmacokinetics of baicalin after oral administration of pure baicalin,< i> Radix scutellariae</i> extract and Huang-Lian-Jie-Du-Tang to rats T Lu, J Song, F Huang, Y Deng, L Xie, G Wang, X Liu Journal of ethnopharmacology 110 (3), 412-418, 2007 | 209 | 2007 |
| Plasma and urinary tanshinol from Salvia miltiorrhiza (Danshen) can be used as pharmacokinetic markers for cardiotonic pills, a cardiovascular herbal medicine T Lu, J Yang, X Gao, P Chen, F Du, Y Sun, F Wang, F Xu, H Shang, ... Drug Metabolism and Disposition 36 (8), 1578-1586, 2008 | 168 | 2008 |
| Simultaneous determination of berberine and palmatine in rat plasma by HPLC–ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du … T Lu, Y Liang, J Song, L Xie, GJ Wang, XD Liu Journal of pharmaceutical and biomedical analysis 40 (5), 1218-1224, 2006 | 125 | 2006 |
| Minimal residual disease dynamics after venetoclax-obinutuzumab treatment: extended off-treatment follow-up from the randomized CLL14 study O Al-Sawaf, C Zhang, T Lu, MZ Liao, A Panchal, S Robrecht, T Ching, ... Journal of Clinical Oncology 39 (36), 4049, 2021 | 105 | 2021 |
| Enduring undetectable MRD and updated outcomes in relapsed/refractory CLL after fixed-duration venetoclax-rituximab JF Seymour, TJ Kipps, BF Eichhorst, J D’Rozario, CJ Owen, S Assouline, ... Blood, The Journal of the American Society of Hematology 140 (8), 839-850, 2022 | 73 | 2022 |
| A survey of new oncology drug approvals in the USA from 2010 to 2015: a focus on optimal dose and related postmarketing activities D Lu, T Lu, M Stroh, RA Graham, P Agarwal, L Musib, CC Li, BL Lum, ... Cancer chemotherapy and pharmacology 77, 459-476, 2016 | 53 | 2016 |
| ‘LC‐electrolyte effects’ improve the bioanalytical performance of liquid chromatography/tandem mass spectrometric assays in supporting pharmacokinetic study for drug discovery L Wang, Y Sun, F Du, W Niu, T Lu, J Kan, F Xu, K Yuan, T Qin, C Liu, C Li Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2007 | 33 | 2007 |
| Pharmacokintics of the Ginkgo Bfollowing intravenous administration of Ginkgo B emulsion in rats WD Chen, Y Liang, L Xie, T Lu, XD Liu, GJ Wang Biological and Pharmaceutical Bulletin 30 (1), 1-5, 2007 | 33 | 2007 |
| High‐performance liquid chromatographic method for the determination and pharmacokinetic study of wogonoside in rat serum after oral administration of traditional Chinese … YX Deng, T Lu, L Xie, XD Liu Biomedical Chromatography 20 (10), 1098-1102, 2006 | 28 | 2006 |
| Integrated two‐analyte population pharmacokinetic model of polatuzumab vedotin in patients with non‐Hodgkin lymphoma D Lu, T Lu, L Gibiansky, X Li, C Li, P Agarwal, CS Shemesh, R Shi, ... CPT: Pharmacometrics & Systems Pharmacology 9 (1), 48-59, 2020 | 27 | 2020 |
| Development of a physiologically based pharmacokinetic model for itraconazole pharmacokinetics and drug–drug interaction prediction Y Chen, F Ma, T Lu, N Budha, JY Jin, JR Kenny, H Wong, CECA Hop, ... Clinical pharmacokinetics 55, 735-749, 2016 | 25 | 2016 |
| Exposure-safety and exposure-efficacy analyses of polatuzumab vedotin in patients with relapsed or refractory diffuse large B-cell lymphoma T Lu, L Gibiansky, X Li, C Li, R Shi, P Agarwal, J Hirata, D Miles, P Chanu, ... Leukemia & Lymphoma 61 (12), 2905-2914, 2020 | 21 | 2020 |
| Simple, sensitive and rapid liquid chromatography/atmospheric pressure chemical ionization mass spectrometric method for the quantitation of Ranolazine in rat plasma Y Liang, L Xie, XD Liu, WD Chen, T Lu, Y Xiong, GJ Wang Rapid Communications in Mass Spectrometry: An International Journal Devoted …, 2006 | 20 | 2006 |
| Determination of limonin in rat plasma by liquid chromatography–electrospray mass spectrometry Y Liang, L Xie, XD Liu, T Lu, GJ Wang, YZ Hu Journal of pharmaceutical and biomedical analysis 39 (5), 1031-1035, 2005 | 20 | 2005 |
| 黄芩苷及其含药血清在大鼠体内的药动学, 药效学相关性研究 宋珏， 路通， 谢林， 王广基， 刘晓东 中国临床药理学与治疗学 11 (12), 1350, 2006 | 19 | 2006 |
| Semi‐mechanism‐based population pharmacokinetic modeling of the Hedgehog pathway inhibitor vismodegib T Lu, B Wang, Y Gao, M Dresser, RA Graham, JY Jin CPT: Pharmacometrics & Systems Pharmacology 4 (11), 680-689, 2015 | 18 | 2015 |
| Gender difference in ranolazine pharmacokinetics in rats XD Liu, L Xie, Y Liang, L Li, T Lu European journal of drug metabolism and pharmacokinetics 28, 119-123, 2003 | 17 | 2003 |
| Bayesian population model of the pharmacokinetics of venetoclax in combination with rituximab in patients with relapsed/refractory chronic lymphocytic leukemia: results from … R Deng, L Gibiansky, T Lu, P Agarwal, H Ding, X Li, S Kshirsagar, D Lu, ... Clinical Pharmacokinetics 58, 1621-1634, 2019 | 14 | 2019 |
